Doxorubicin-loaded poly(ε-caprolactone)-Pluronic micelle for targeted therapy of esophageal cancer

MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background

(2016) Zhimin Ye et al.   CANCER LETTERS

Nanoparticle formulation of ormeloxifene for pancreatic cancer

(2015) Sheema Khan et al.   BIOMATERIALS

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance

(2015) He Wang et al.   Oncotarget

The Global Burden of Cancer 2013

(2015) Christina Fitzmaurice et al.   JAMA Oncology

Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

(2014) M. T. Marino et al.   ANNALS OF ONCOLOGY

Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles

(2014) Pengfei Zhao et al.   BIOMATERIALS

MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors

(2014) Paolo Luraghi et al.   CANCER RESEARCH

Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer

(2014) Y. Hamai et al.   DISEASES OF THE ESOPHAGUS

Global incidence of oesophageal cancer by histological subtype in 2012

(2014) Melina Arnold et al.   GUT

miRNA-34a Suppresses Cell Proliferation and Metastasis by Targeting CD44 in Human Renal Carcinoma Cells

(2014) Gan Yu et al.   JOURNAL OF UROLOGY

MicroRNA 34a Inhibits Beige and Brown Fat Formation in Obesity in Part by Suppressing Adipocyte Fibroblast Growth Factor 21 Signaling and SIRT1 Function

(2014) T. Fu et al.   MOLECULAR AND CELLULAR BIOLOGY

Multifunctional Nanoparticles as Nanocarrier for Vincristine Sulfate Delivery To Overcome Tumor Multidrug Resistance

(2014) Yuan Wang et al.   MOLECULAR PHARMACEUTICS

The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery

(2014) Hiromasa Fujita   SURGERY TODAY

Impact of Neoadjuvant Chemoradiotherapy on Postoperative Course after Curative-intent Transthoracic Esophagectomy in Esophageal Cancer Patients

(2013) Dirk J. Bosch et al.   ANNALS OF SURGICAL ONCOLOGY

Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer

(2013) Joachim Rom et al.   ANTI-CANCER DRUGS

Timed-Release Polymer Nanoparticles

(2013) Nguyen T. D. Tran et al.   BIOMACROMOLECULES

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles

(2013) Shanthi Ganesh et al.   JOURNAL OF CONTROLLED RELEASE

Cell cycle changes mediated by the p53/miR-34c axis are involved in the malignant transformation of human bronchial epithelial cells by benzo[a]pyrene

(2013) Zhuyu Han et al.   TOXICOLOGY LETTERS

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

(2012) Laisheng Li et al.   CLINICAL AND EXPERIMENTAL MEDICINE

CD44: a validated target for improved delivery of cancer therapeutics

(2012) Sukhen C Ghosh et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles

(2012) Qin Liu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme

(2012) D Yin et al.   ONCOGENE

miR-34a Expression, Cell Cycle Arrest and Cell Death of Malignant Mesothelioma Cells upon Treatment with Radiation, Docetaxel or Combination Treatment

(2012) Taha Ghawanmeh et al.   ONCOLOGY

The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin

(2009) Xiao-Bing Xiong et al.   BIOMATERIALS